PMID- 36561561 OWN - NLM STAT- MEDLINE DCOM- 20221226 LR - 20230127 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 13 DP - 2022 TI - Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018. PG - 1071465 LID - 10.3389/fendo.2022.1071465 [doi] LID - 1071465 AB - OBJECTIVE: Diabetic kidney disease (DKD) is the most common chronic kidney disease (CKD) and has the highest prevalence of end-stage kidney disease (ESKD) globally, owing mostly to the rise in Type 2 diabetes mellitus (T2DM) correlated with obesity. Current research suggested that the immune response and inflammation may play a role in the pathophysiology of T2DM. The systemic immune-inflammation index (SII) is a novel and integrated inflammatory biomarker that has not yet been linked to DKD. We aimed to identify the potential relationship between SII and DKD. METHODS: In the National Health and Nutrition Examination Survey (NHANES) between 2011 and 2018, the current cross-sectional study was conducted among adults with T2DM. SII was calculated as the platelet count x neutrophil count/lymphocyte count. DKD was diagnosed with impaired glomerular filtration rate (< 60 mL/min/1.73 m(2) assessed by using the Chronic Kidney Disease Epidemiology Collaboration algorithm), albuminuria (urine albumin to creatinine ratio >/= 30 mg/g), or both in T2DM patients. To investigate the independent association between SII and DKD, weighted univariate and multivariable logistic regression analyses and subgroup analyses were performed. RESULTS: The study involved 3937 patients in total, of whom 1510 (38.4%) had DKD for the diagnosis. After adjustment for covariates, multivariable logistic regression revealed that a high SII level was associated with increased likelihood of DKD (OR = 1.42, 95% CI: 1.10-1.83, P = 0.01). Subgroup analyses and interaction tests revealed that age, gender, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (ACR), body mass index (BMI), hypertension, hyperlipidemia, anti-inflammation therapy (yes or no), metformin use (yes or no), and insulin use (yes or no) had no significant dependence on this positive relationship (all p for interaction >0.05). CONCLUSIONS: Our results indicate that the higher SII level is associated with DKD in T2DM patients. The SII could be a cost-effective and straightforward approach to detecting DKD. This needs to be verified in further prospective investigations. CI - Copyright (c) 2022 Guo, Song, Sun, Du, Cai, You, Fu and Shao. FAU - Guo, Wencong AU - Guo W AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Song, Yancheng AU - Song Y AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Sun, Yan AU - Sun Y AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Du, Huasheng AU - Du H AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Cai, Yan AU - Cai Y AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - You, Qingqing AU - You Q AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Fu, Haixia AU - Fu H AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Shao, Leping AU - Shao L AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221206 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 RN - AYI8EX34EU (Creatinine) RN - 0 (Albumins) SB - IM MH - Adult MH - Humans MH - *Diabetic Nephropathies/diagnosis/epidemiology/etiology MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Nutrition Surveys MH - Creatinine MH - Cross-Sectional Studies MH - Inflammation/epidemiology/complications MH - *Renal Insufficiency, Chronic/complications/epidemiology MH - Albumins PMC - PMC9763451 OTO - NOTNLM OT - NHANES OT - diabetic kidney disease OT - population-based study OT - systemic immune-inflammation index OT - type 2 diabetes mellitus COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/12/24 06:00 MHDA- 2022/12/27 06:00 PMCR- 2022/01/01 CRDT- 2022/12/23 02:30 PHST- 2022/10/19 00:00 [received] PHST- 2022/11/21 00:00 [accepted] PHST- 2022/12/23 02:30 [entrez] PHST- 2022/12/24 06:00 [pubmed] PHST- 2022/12/27 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2022.1071465 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2022 Dec 6;13:1071465. doi: 10.3389/fendo.2022.1071465. eCollection 2022.